Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial
Introduction Lower diversity of the gut microbiome prior to allogeneic haematopoietic cell transplantation (HCT) correlates with reduced survival after the intervention. Most patients undergoing HCT for a haematological malignancy have previously received intensive chemotherapy, resulting in prolong...
Saved in:
Main Authors: | Julian R Marchesi, Emma Nicholson, Benjamin H Mullish, Renuka Palanicawandar, Graham Wheeler, Francesca Kinsella, Andrew J Innes, Lauren A Roberts, Shian Anim-Burton, Lee Webber, Nicholas A Johnson, Rohma Ghani, Pakhshan Farshi, Anjum B Khan, Panagiotis Kottaridis, Pramila Krishnamurthy, Frances Davies, Jiří Pavlů |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/12/e093120.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial
by: Laith Alrubaiy, et al.
Published: (2025-01-01) -
Transplant Trial Watch
by: Simon R. Knight, et al.
Published: (2024-12-01) -
Transplant Trial Watch
by: John M. O’Callaghan, et al.
Published: (2025-01-01) -
Transplant Trial Watch
by: John M. O’Callaghan, et al.
Published: (2024-11-01) -
Role of Mast Cells and Type 2 Innate Lymphoid (ILC2) Cells in Lung Transplantation
by: Esmaeil Mortaz, et al.
Published: (2018-01-01)